NDAORALCAPSULE, EXTENDED RELEASE
Approved
Dec 2014
Lifecycle
Peak
Competitive Pressure
8/100
Mechanism of Action
medications: memantine hydrochloride and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer's disease. Memantine Persistent activation of central nervous system NMDA receptors by the excitatory amino acid glutamate has been hypothesized to…
Loss of Exclusivity
LOE Date
Dec 5, 2029
45 months away
Patent Expiry
Dec 5, 2029
Patent Records (3)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8039009 | Mar 24, 2029 | U-1641 | |
| 8039009*PED | Sep 24, 2029 | — | |
| 8058291 | Dec 5, 2029 | U-1641 |